We are live on
!
Find out more
Vanguard Capital Management Portfolio holdings
AUM
$4.68T
This Fund
S&P 500
This Quarter
Est. Return
-1.1%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.04T
AUM Growth
–
Cap. Flow
+$4.22T
Cap. Flow
% of AUM
104.32%
Top 10 Holdings %
Top 10 Hldgs %
32.57%
Holding
4,062
New
4,062
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$282B |
| 2 |
Apple
AAPL
|
+$248B |
| 3 |
Microsoft
MSFT
|
+$202B |
| 4 |
Amazon
AMZN
|
+$139B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$119B |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.5% |
| 2 | Financials | 12.85% |
| 3 | Healthcare | 9.93% |
| 4 | Consumer Discretionary | 9.89% |
| 5 | Communication Services | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Candel Therapeutics
CADL
$930M
| $12.1M | ﹤0.01% |
+2,462,757
| New | +$13.4M |
|
2627
Immuneering
IMRX
$338M
| $12.1M | ﹤0.01% |
+2,288,341
| New | +$11.7M |
|
|
SHOE
2628
Shoe Station Group
SHOE
$421M
| $12.1M | ﹤0.01% |
+773,338
| New | +$14.7M |
|
|
SRTA
2629
Strata Critical Medical Inc
SRTA
$522M
| $12M | ﹤0.01% |
+2,872,446
| New | +$13.8M |
|
2630
Viemed Healthcare
VMD
$345M
| $12M | ﹤0.01% |
+1,303,384
| New | +$10.8M |
|
2631
Monopar Therapeutics
MNPR
$799M
| $12M | ﹤0.01% |
+218,463
| New | +$13.2M |
|
2632
TSMC
TSM
$2.14T
| $12M | ﹤0.01% |
+35,361
| New | +$12.2M |
|
|
INR
2633
Infinity Natural Resources
INR
$258M
| $11.9M | ﹤0.01% |
+675,915
| New | +$11M |
|
2634
Anavex Life Sciences
AVXL
$298M
| $11.9M | ﹤0.01% |
+3,863,950
| New | +$16.7M |
|
2635
SITE Centers
SITC
$156M
| $11.8M | ﹤0.01% |
+2,193,943
| New | +$13.5M |
|
2636
MGP Ingredients
MGPI
$383M
| $11.8M | ﹤0.01% |
+643,764
| New | +$14.4M |
|
2637
Alvotech
ALVO
$1.31B
| $11.8M | ﹤0.01% |
+3,410,447
| New | +$15M |
|
2638
Standard BioTools
LAB
$269M
| $11.8M | ﹤0.01% |
+12,816,070
| New | +$15.5M |
|
2639
Aspen Aerogels
ASPN
$483M
| $11.8M | ﹤0.01% |
+3,436,156
| New | +$11.6M |
|
2640
Acco Brands
ACCO
$390M
| $11.7M | ﹤0.01% |
+3,913,839
| New | +$14.7M |
|
2641
Ginkgo Bioworks
DNA
$440M
| $11.7M | ﹤0.01% |
+1,914,428
| New | +$15.9M |
|
2642
Sonida Senior Living
SNDA
$1.88B
| $11.7M | ﹤0.01% |
+363,741
| New | +$12.2M |
|
2643
Kelly Services Class A
KELYA
$559M
| $11.7M | ﹤0.01% |
+1,323,517
| New | +$12.6M |
|
2644
Nathan's Famous
NATH
$400M
| $11.7M | ﹤0.01% |
+116,170
| New | +$11.5M |
|
2645
Wave Life Sciences
WVE
$1B
| $11.7M | ﹤0.01% |
+1,611,853
| New | +$21M |
|
2646
MBIA
MBI
$252M
| $11.7M | ﹤0.01% |
+1,975,239
| New | +$12.6M |
|
2647
Ovid Therapeutics
OVID
$555M
| $11.7M | ﹤0.01% |
+5,258,246
| New | +$9.4M |
|
2648
Liberty Latin America Class C
LILAK
$1.65B
| $11.7M | ﹤0.01% |
+1,453,724
| New | +$10.4M |
|
2649
CNA Financial
CNA
$13.5B
| $11.7M | ﹤0.01% |
+253,747
| New | +$12M |
|
2650
Puma Biotechnology
PBYI
$455M
| $11.6M | ﹤0.01% |
+1,817,681
| New | +$11.7M |
|
Similar funds
Vanguard Capital Management's Q1 2026 Portfolio in Review
Q1 2026 is the first quarter with a 13F filing on record for Vanguard Capital Management, which disclosed 4,062 positions worth $4.04T. Its ten largest holdings account for 33% of the portfolio.
Its largest position is NVIDIA: 1,538,550,382 shares worth $268B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, followed by Financials and Healthcare.
- Vanguard Capital Management's largest Q1 2026 buy was NVIDIA: 1,538,550,382 shares worth $268B.
- Vanguard Capital Management's ten largest holdings make up 33% of its $4.04T portfolio in Q1 2026.
- Vanguard Capital Management disclosed 4,062 positions in Q1 2026, its first 13F filing on record.
Based on Vanguard Capital Management's 13F filing for Q1 2026, filed 8 May 2026.